Company intelligence / Profile preview

ProstaLund

Lund, Skåne, Sweden

Ownership: Private
Employees: ~15
Development stage: Other

Overview

ProstaLund is a Swedish medical technology company specializing in the treatment of Benign Prostatic Hyperplasia (BPH). The company's flagship product, CoreTherm, is a patented thermotherapy method that utilizes microwave energy (TUMT) to treat enlarged prostates in a minimally invasive, office-based setting. This procedure serves as an alternative to major surgery like TURP and long-term pharmacological treatments, emphasizing patient safety and clinical efficacy. ProstaLund also provides diagnostic and supportive tools, such as the Schelin Catheter and CoreFlow, to optimize urological care and treatment outcomes.

Therapeutic areas: Men's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

CapioAleris

Beyond the preview

Go deeper on ProstaLund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProstaLund.

Explore the full profile